Cost-effectiveness of Consolidation Durvalumab for Inoperable Stage III Non-Small Cell Lung Cancer in Vietnam
BMJ open（2024）
Key words
health economics,lung diseases,chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined